iResearch Savannah ( Site 0023) — Savannah, Georgia

iResearch Savannah ( Site 0023) is a clinical research site located in Savannah, Georgia, United States 31405.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

iResearch Savannah ( Site 0023) has participated in 1 clinical trials.

Therapeutic areas: Alzheimer's Disease, Mild Cognitive Impairment.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for iResearch Savannah ( Site 0023)?

iResearch Savannah ( Site 0023) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has iResearch Savannah ( Site 0023) conducted?

iResearch Savannah ( Site 0023) has 1 clinical trials on record. Their work covers Alzheimer's Disease, Mild Cognitive Impairment.

Is iResearch Savannah ( Site 0023) accredited by Crixeo Health?

iResearch Savannah ( Site 0023) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about iResearch Savannah ( Site 0023)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.